Meeting on the Mesa 2026 has ended. This guide stays up as the record of who was there. Next: Meeting on the Mesa 2027, Oct 18–20, 2027 in Phoenix
Investors at Meeting on the Mesa 2026
Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website
46 investors are at Meeting on the Mesa 2026 — 7 presentations on the program. Most represented: OrbiMed (2 on the program), Delin Ventures (1 on the program), Gordon MD Global Investments (1 on the program). 8 of them have their own page in this guide. As of Oct 6, 2026.
Focus area
Top represented
Showing 1–19 of 46 organizations
| Organization | Meeting on the Mesa 2026 Attendance |
|---|---|
Sumitomo Corporation Tokyo, Japan | ◆Gold Sponsor |
Invests in and operates businesses across healthcare, pharmaceuticals, infrastructure, finance, and other industries. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
OrbiMed New York, NY | |
Invests in healthcare and life sciences companies through venture capital, private equity, public equity, and royalty financing. | Panel Mon, Oct 5 9:00am Chair Mon, Oct 5 11:45am Patient Spotlight: a Metachromatic Leukodystrophy Advocate |
Delin Ventures London, United Kingdom | |
Invests in and builds early-stage cell therapy companies and related life-sciences infrastructure, alongside technology startups. | Workshop Mon, Oct 5 8:00am |
Gordon MD Global Investments Beverly Hills, CA | |
Manages private and public funds investing in biopharmaceutical companies across the United States, Europe and Japan. | |
Jennison New York, NY | |
Investment manager offering active equity and fixed-income strategies to institutional clients. | |
Novo Holdings Copenhagen, Denmark | |
Invests in life science companies and manages the Novo Nordisk Foundation’s assets across public and private markets. | Panel Mon, Oct 5 2:30pm |
Samsara Biocapital Palo Alto, CA | |
Invests in biotechnology companies developing transformative therapeutics. | |
28 Capital Boston, MA | |
Life sciences venture fund that forms and invests in early-stage biotech and therapeutic companies. | Attending On the meeting’s published attendee list |
4BIO Capital London, United Kingdom | |
Venture capital firm investing in early-stage companies developing cell, gene, RNA and other advanced therapies. | Attending On the meeting’s published attendee list |
6C 683 Capital New York, NY | |
Investment manager running pooled funds and taking positions in publicly traded companies, including biotechnology firms. | Attending On the meeting’s published attendee list |
AO Alpha Omega Investment & Development | |
Attending On the meeting’s published attendee list | |
Altaris New York, NY | |
Healthcare investment firm that acquires and builds companies across healthcare subsectors. | Attending On the meeting’s published attendee list |
Altius Bioventures Capital North Vancouver, Canada | |
Invests in and co-builds early-stage companies developing tools and technologies for advanced therapy manufacturing, testing and logistics. | Attending On the meeting’s published attendee list |
ARCH Venture Partners Chicago, IL | |
Invests in and helps build early-stage life science and technology companies from scientific discoveries. | Attending On the meeting’s published attendee list |
Avant Bio New York, NY | |
Invests in life science, healthtech and therapeutic-enabling technology companies. | Attending On the meeting’s published attendee list |
Avego Management Alpharetta, GA | |
Invests in healthcare and biotech companies through growth capital and other investment strategies. | Attending On the meeting’s published attendee list |
Balyasny Asset Management Chicago, IL | |
Multi-strategy asset manager investing across public and private markets for institutional and other investors. | Attending On the meeting’s published attendee list |
BroadOak Washington, DC | |
Invests growth capital and provides investment banking services to life sciences tools, diagnostics, and biopharma services companies. | Attending On the meeting’s published attendee list |
Canaccord Genuity Toronto, Canada | |
Provides investment banking, M&A advisory, equity research, and sales and trading services to corporate and institutional clients. | Attending On the meeting’s published attendee list |
Find buyers from investors
Tell us what you sell and we’ll find the people at these investors most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse Meeting on the Mesa 2026 by
Organization type
Focus area
Everyone
Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction